将TERT促进子突变整合到乳头甲状腺癌风险分层中

Ji Hyun Yoo1, Bo Ram Kim1, Da Eun Leem2

  • 1Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Endocrine connections
|December 22, 2025
PubMed
概括

端粒酶逆转录酶 (TERT) 促进子突变表明具有较差短期结果的侵袭性乳头甲状腺癌 (PTC). 纳入 TERT 状态完善了风险分层,以更好地管理患者.